Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 50 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Συντάκτης is Lambrinoudaki, Irene [Clear All Filters]
(2019).
Therapeutic strategies for type 2 diabetes mellitus in women after menopause..
Maturitas. 126, 69-72.
(2019). On the use and abuse of register studies: The case of menopausal hormone therapy..
Maturitas. 123, 91-92.
(2019). Abnormal fasting, post-load or combined glucose values on oral glucose tolerance test and pregnancy outcomes in women with gestational diabetes mellitus..
Diabetes Res Clin Pract. 161, 108048.
(2020). Breast cancer risk and hormone replacement therapy: Whether "absolute" or "relative", the conundrum remains..
Eur J Obstet Gynecol Reprod Biol. 244, 190-191.
(2020). Early menopause is associated with increased risk of arterial hypertension: A systematic review and meta-analysis..
Maturitas. 135, 74-79.
(2020). Estrogen and bones after menopause: a reappraisal of data and future perspectives..
Hormones (Athens).
(2020). Management of depressive symptoms in peri- and postmenopausal women: EMAS position statement..
Maturitas. 131, 91-101.
(2020).
(2020). The Mediterranean diet and menopausal health: An EMAS position statement..
Maturitas. 139, 90-97.
(2020). Menopausal hormone therapy for women with obesity in the era of COVID-19..
Case Rep Womens Health. 27, e00233.
(2020). Menopause in women with multiple sclerosis: A systematic review..
Maturitas. 135, 68-73.
(2020). Menopause symptom management in women with dyslipidemias: An EMAS clinical guide..
Maturitas. 135, 82-88.
(2020). Genitourinary syndrome of menopause: a systematic review on prevalence and treatment..
Menopause. 28(6), 706-716.
(2021). Global consensus recommendations on menopause in the workplace: A European Menopause and Andropause Society (EMAS) position statement..
Maturitas. 151, 55-62.
(2021). Hormone therapy regimens for managing the menopause and premature ovarian insufficiency..
Best Pract Res Clin Endocrinol Metab. 35(6), 101561.
(2021). Obesity, metabolic syndrome, and cancer: pathophysiological and therapeutic associations..
Endocrine. 74(3), 478-497.
(2021). Topical estrogens and non-hormonal preparations for postmenopausal vulvovaginal atrophy: An EMAS clinical guide..
Maturitas. 148, 55-61.
(2021). Updates on the treatment of invasive breast cancer: Quo Vadimus?.
Maturitas. 145, 64-72.
(2021). Bone Health in Patients with Dyslipidemias: An Underestimated Aspect..
Int J Mol Sci. 23(3),
(2022). The essential menopause curriculum for healthcare professionals: A European Menopause and Andropause Society (EMAS) position statement..
Maturitas. 158, 70-77.
(2022). The interplay between diabetes mellitus and menopause: clinical implications..
Nat Rev Endocrinol.
(2022). Menopausal hormone therapy in women with dyslipidemia and nonalcoholic fatty liver disease..
Hormones (Athens).
(2022). Menopause, wellbeing and health: A care pathway from the European Menopause and Andropause Society..
Maturitas. 163, 1-14.
(2022). Menopause-associated risk of cardiovascular disease..
Endocr Connect. 11(4),
(2022).